☰

Bethany L. Niell, Ph.D. - Publications

Affiliations: 
2005 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Public Health, Oncology, Molecular Biology
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Conley CC, Rodriguez JD, McIntyre M, Brownstein NC, Niell BL, O'Neill SC, Vadaparampil ST. Self-reported barriers to screening breast MRI among women at high risk for breast cancer. Breast Cancer Research and Treatment. PMID 37640965 DOI: 10.1007/s10549-023-07085-w  0.309
2022 Wang X, Chang MD, Lee MC, Niell BL. The Breast Cancer Screening and Timing of Breast MRI-Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center. Current Oncology (Toronto, Ont.). 29: 2119-2131. PMID 35323371 DOI: 10.3390/curroncol29030171  0.384
2021 Brown A, Lourenco AP, Niell BL, Cronin B, Dibble EH, DiNome ML, Goel MS, Hansen J, Heller SL, Jochelson MS, Karrington B, Klein KA, Mehta TS, Newell MS, et al. ACR Appropriateness Criteria® Transgender Breast Cancer Screening. Journal of the American College of Radiology : Jacr. 18: S502-S515. PMID 34794604 DOI: 10.1016/j.jacr.2021.09.005  0.341
2021 Niell BL, Augusto B, McIntyre M, Conley CC, Gerke T, Roetzheim R, Garcia J, Vadaparampil ST. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography. Ajr. American Journal of Roentgenology. 1-8. PMID 33978450 DOI: 10.2214/AJR.20.23333  0.367
2020 Niell BL, Abdalah M, Stringfield O, Raghunand N, Ataya D, Gillies R, Balagurunathan Y. Quantitative measures of background parenchymal enhancement predict breast cancer risk. Ajr. American Journal of Roentgenology. PMID 32876474 DOI: 10.2214/Ajr.20.23804  0.34
2020 Conley CC, Niell BL, Augusto BM, McIntyre M, Roetzheim R, Funaro K, Vadaparampil ST. Uptake of Risk Appropriate Behaviors After Breast Cancer Risk Stratification in the Mammography Screening Population. Journal of the American College of Radiology : Jacr. PMID 32229274 DOI: 10.1016/j.jacr.2020.02.019  0.396
2019 Roark AA, Dang PA, Niell BL, Halpern EF, Lehman CD. Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer. Ajr. American Journal of Roentgenology. 212: 271-279. PMID 30540208 DOI: 10.2214/AJR.18.19916  0.315
2018 Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, Garber JE, Gray R, Greenberg CC, Greenup R, Hansen NM, Harris RE, Heerdt AS, Helsten T, Hodgkiss L, ... ... Niell BL, et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 1362-1389. PMID 30442736 DOI: 10.6004/jnccn.2018.0083  0.336
2018 Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. Journal of the American College of Radiology : Jacr. PMID 29371086 DOI: 10.1016/j.jacr.2017.11.034  0.357
2017 Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA, Lourenco AP, Nance KJ, Niell BL, Slanetz PJ, et al. ACR Appropriateness Criteria(®) Breast Cancer Screening. Journal of the American College of Radiology : Jacr. 14: S383-S390. PMID 29101979 DOI: 10.1016/j.jacr.2017.08.044  0.327
2017 Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Screening for Breast Cancer. Radiologic Clinics of North America. 55: 1145-1162. PMID 28991557 DOI: 10.1016/j.rcl.2017.06.004  0.313
2017 Amornsiripanitch N, Mangano M, Niell BL. Screening Mammography: Patient Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk. Ajr. American Journal of Roentgenology. 1-8. PMID 28225643 DOI: 10.2214/AJR.16.16779  0.401
2010 Greenwood CM, Sun S, Veenstra J, Hamel N, Niell B, Gruber S, Foulkes WD. How old is this mutation? - a study of three Ashkenazi Jewish founder mutations. Bmc Genetics. 11: 39. PMID 20470408 DOI: 10.1186/1471-2156-11-39  0.522
2004 Friedenson B, Niell BL, Rennert G, Bonner JD, Gruber SB. Re: BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer (multiple letters) [3] Journal of the National Cancer Institute. 96: 1184-1186. PMID 15292392  0.622
2004 Niell BL, Rennert G, Bonner JD, Almog R, Tomsho LP, Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. Journal of the National Cancer Institute. 96: 15-21. PMID 14709734 DOI: 10.1093/Jnci/Djh008  0.604
2004 Niell BL, Rennert G, Bonner JD, Gruber SB. RESPONSE: Re: BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer Jnci Journal of the National Cancer Institute. 96: 1185-1186. DOI: 10.1093/Jnci/Djh237  0.594
2003 Niell BL, Long JC, Rennert G, Gruber SB. Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim. American Journal of Human Genetics. 73: 1250-60. PMID 14624392 DOI: 10.1086/379926  0.471
2001 Erson AE, Niell BL, DeMers SK, Rouillard JM, Hanash SM, Petty EM. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells Neoplasia. 3: 521-526. PMID 11774034 DOI: 10.1038/Sj.Neo.7900187  0.336
Show low-probability matches.